Literature DB >> 21935757

Hepatoid Adenocarcinoma of the Gallbladder : Case Report and Literature Review.

Anastasios J Karayiannakis1, Stylianos Kakolyris2, Alexandra Giatromanolaki3, Nikos Courcoutsakis4, Helen Bolanaki5, Leonidas Chelis2, Efthimios Sivridis3, Constantinos Simopoulos5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 21935757     DOI： 10.1007/s12029-011-9326-5

Source DB:  PubMed          Journal:  J Gastrointest Cancer


× No keyword cloud information.
  30 in total

1.  Hepatoid adenocarcinoma of the lung: report of a case of an unusual alpha-fetoprotein-producing lung tumor.

Authors:  L Arnould; F Drouot; P Fargeot; A Bernard; P Foucher; F Collin; T Petrella
Journal:  Am J Surg Pathol       Date:  1997-09       Impact factor: 6.394

Review 2.  Emerging strategies in the treatment of advanced hepatocellular carcinoma: the role of targeted therapies.

Authors:  R Lord; A Suddle; P J Ross
Journal:  Int J Clin Pract       Date:  2011-02       Impact factor: 2.503

3.  Hepatoid carcinoma of the pancreas.

Authors:  Khalista Hughes; Steven Kelty; Robert Martin
Journal:  Am Surg       Date:  2004-11       Impact factor: 0.688

4.  Hepatoid adenocarcinoma of the endometrium associated with alpha-fetoprotein production.

Authors:  Y Hoshida; T Nagakawa; S Mano; K Taguchi; K Aozasa
Journal:  Int J Gynecol Pathol       Date:  1996-07       Impact factor: 2.762

5.  Alpha-fetoprotein-producing early gastric cancer of the remnant stomach: report of a case.

Authors:  Yutaka Shibata; Kouhei Sato; Masashi Kodama; Hiroshi Nanjyo
Journal:  Surg Today       Date:  2007-10-25       Impact factor: 2.549

6.  A case of hepatoid carcinoma of the ovary.

Authors:  H Ozan; H Oztürk Nazlioğlu; S Ozuysal
Journal:  Eur J Gynaecol Oncol       Date:  2008       Impact factor: 0.196

Review 7.  Sorafenib: a review of its use in advanced hepatocellular carcinoma.

Authors:  Gillian M Keating; Armando Santoro
Journal:  Drugs       Date:  2009       Impact factor: 9.546

Review 8.  Primary hepatoid adenocarcinoma of the uterine cervix.

Authors:  K Kato; K Suzuka; T Osaki; M Itami; N Tanaka
Journal:  Int J Gynecol Cancer       Date:  2007-03-15       Impact factor: 3.437

9.  Hepatoid adenocarcinoma in the lung.

Authors:  Yasufumi Hayashi; Yoshinori Takanashi; Hiroyuki Ohsawa; Haruhiko Ishii; Yukio Nakatani
Journal:  Lung Cancer       Date:  2002-11       Impact factor: 5.705

10.  Successful paclitaxel-based chemotherapy for an alpha-fetoprotein-producing gastric cancer patient with multiple liver metastases.

Authors:  Hiromitsu Takeyama; Hirozumi Sawai; Takehiro Wakasugi; Hiroki Takahashi; Yoichi Matsuo; Nobuo Ochi; Akira Yasuda; Mikinori Sato; Yuji Okada; Hitoshi Funahashi; Yoshimi Akamo; Tadao Manabe
Journal:  World J Surg Oncol       Date:  2007-07-16       Impact factor: 2.754
View more
  6 in total

1.  Hepatoid adenocarcinoma of the peritoneal cavity: Prolonged survival after debulking surgery and 5-fluorouracil, leucovorin and oxaliplatin (FOLFOX) therapy.

Authors:  Zarah Dulce F Lucas; Manasi Shah; Anshu Trivedi; Mark E Dailey
Journal:  J Gastrointest Oncol       Date:  2012-06

2.  Hepatoid carcinoma of the pancreas combined with serous cystadenoma: a case report and review of the literature.

Authors:  Fadl H Veerankutty; Varghese Yeldho; Shabeer Ali Tu; B Venugopal; Krishnan Sarojam Manoj; C Vidhya
Journal:  Hepatobiliary Surg Nutr       Date:  2015-10       Impact factor: 7.293

3.  Hepatoid adenocarcinoma of the lung: Presenting mediastinal metastasis without transfer to the liver.

Authors:  Yi-Qun Che; Shuang Wang; Yang Luo; Jing-Bo Wang; Lu-Hua Wang
Journal:  Oncol Lett       Date:  2014-04-15       Impact factor: 2.967

4.  AFP-producing hepatoid adenocarcinoma (HAC) of peritoneum and omentum: a case report and literature review.

Authors:  Man Zou; Yanhui Li; Yuhong Dai; Li Sun; Tingting Huang; Xianglin Yuan; Hong Qiu
Journal:  Onco Targets Ther       Date:  2019-09-18       Impact factor: 4.147

5.  Chemotherapy of metastatic hepatoid adenocarcinoma: Literature review and two case reports with cisplatin etoposide.

Authors:  Victor Simmet; Margot Noblecourt; Thibaut Lizée; Benjamin Morvant; Sylvie Girault; Patrick Soulié; Olivier Capitain
Journal:  Oncol Lett       Date:  2017-10-25       Impact factor: 2.967

6.  Neoadjuvant modified-FOLFIRINOX followed by surgical resection of both the primary and metastatic tumors of a pancreatic hepatoid carcinoma with synchronous liver metastasis: A case report.

Authors:  Tao Ma; Xueli Bai; Guogang Li; Shumei Wei; Tingbo Liang
Journal:  Medicine (Baltimore)       Date:  2017-10       Impact factor: 1.889
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.